Adynxx Inc
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-… Read more
Adynxx Inc (ADYX) - Total Liabilities
Latest total liabilities as of September 2019: $14.32 Million USD
Based on the latest financial reports, Adynxx Inc (ADYX) has total liabilities worth $14.32 Million USD as of September 2019.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Adynxx Inc - Total Liabilities Trend (2000–2018)
This chart illustrates how Adynxx Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Adynxx Inc Competitors by Total Liabilities
The table below lists competitors of Adynxx Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First Abacus Financial Holdings Corp
PSE:FAF
|
Philippines | ₱6.92 Billion |
|
Bright Kindle Resources & Investments Inc
PSE:BKR
|
Philippines | ₱1.67 Billion |
|
Peer To Peer Network
PINK:PTOP
|
USA | $1.02 Million |
|
HAW Capital Corp
V:HAW-P
|
Canada | CA$61.62K |
|
Mushrooms Inc.
PINK:MSRM
|
USA | $65.00K |
|
BANK INTL INDON -A-
BE:BOZA
|
Germany | €160.63 Trillion |
Liability Composition Analysis (2000–2018)
This chart breaks down Adynxx Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 4.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adynxx Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adynxx Inc (2000–2018)
The table below shows the annual total liabilities of Adynxx Inc from 2000 to 2018.
| Year | Total Liabilities | Change |
|---|---|---|
| 2018-12-31 | $1.43 Million | -91.74% |
| 2017-12-31 | $17.27 Million | -22.92% |
| 2016-12-31 | $22.41 Million | -39.97% |
| 2015-12-31 | $37.33 Million | +417.53% |
| 2014-12-31 | $7.21 Million | +106.14% |
| 2013-12-31 | $3.50 Million | +121.94% |
| 2012-12-31 | $1.58 Million | +303.19% |
| 2011-12-31 | $391.01K | +3.37% |
| 2010-12-31 | $378.26K | +112.10% |
| 2009-12-31 | $178.34K | -39.00% |
| 2008-12-31 | $292.38K | -78.78% |
| 2007-12-31 | $1.38 Million | +2.91% |
| 2006-12-31 | $1.34 Million | -1.76% |
| 2005-12-31 | $1.36 Million | +18.15% |
| 2004-12-31 | $1.15 Million | +42.88% |
| 2003-12-31 | $807.16K | +31930.12% |
| 2002-12-31 | $2.52K | -95.83% |
| 2001-12-31 | $60.43K | +20.43% |
| 2000-12-31 | $50.18K | -- |